Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Post Market
Current status date:
2005-07-13
Original market date: See footnote 1
1982-12-31
Product name:
CHOLEDYL SA TABLETS 600MG
DIN:
00536709
Product Monograph/Veterinary Labelling:
Date:
2005-07-05
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
ERFA CANADA 2012 INC
312
1600 Notre Dame St. West
Montreal
Quebec
Canada
H3J 1M1
Class:
Human
Dosage form(s):
Tablet (Extended-Release)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
86:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R03DA02 CHOLINE THEOPHYLLINATE
Active ingredient group (AIG) number:See footnote5
0100551007
| Active ingredient(s) | Strength |
|---|---|
| OXTRIPHYLLINE | 600 MG |